| PERIOD ENDING | 3-Oct-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 93,841 | 90,779 | 107,652 | 116,609 | | Cost of Revenue | 62,563 | 56,175 | 66,139 | 72,388 | | | Gross Profit | 31,278 | 34,604 | 41,513 | 44,221 | | | Operating Expenses | | Research Development | 4,990 | 4,199 | 3,874 | 3,259 | | Selling General and Administrative | 30,188 | 25,597 | 25,892 | 29,023 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,900) | 4,808 | 11,747 | 11,939 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 545 | 235 | (858) | 1,411 | | Earnings Before Interest And Taxes | (3,355) | 5,043 | 10,889 | 13,350 | | Interest Expense | 413 | 548 | 555 | 508 | | Income Before Tax | (3,768) | 4,495 | 10,334 | 12,842 | | Income Tax Expense | (814) | 1,346 | 2,886 | 3,091 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,954) | 3,149 | 7,448 | 9,751 | | | Non-recurring Events | | Discontinued Operations | (25) |
-
| 25 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,979) | 3,149 | 7,473 | 9,751 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,979) | $3,149 | $7,473 | $9,751 |
|
0.02% Nasdaq 
Income Statement
